IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

NSE:IOLCP Revenue

In the fiscal year ending March 31, 2026, IOL Chemicals and Pharmaceuticals had annual revenue of 23.19B INR with 11.54% growth. IOL Chemicals and Pharmaceuticals had revenue of 6.19B in the quarter ending March 31, 2026, with 17.37% growth.

• Revenue: 23.19B
• Revenue Growth: +11.54%
• P/S Ratio: 1.65
• Revenue / Employee: 8.02M
• Employees: 2,891
• Market Cap: 38.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	23.19B	2.40B	11.54%
Mar 31, 2025	20.79B	-535.80M	-2.51%
Mar 31, 2024	21.33B	-843.20M	-3.80%
Mar 31, 2023	22.17B	330.90M	1.52%
Mar 31, 2022	21.84B	2.17B	11.03%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error